New Alzheimer's drug candidate J4 enters first human safety trials
Knowledge-focused
Recruiting now
This early-stage study tests whether a new drug called J4 is safe for people. It is the first time J4 is given to humans, and only healthy adults aged 18 to 64 can join. The main goal is to check for side effects and how the drug moves through the body. This study does not treat …
Phase: PHASE1 • Sponsor: Academia Sinica, Taiwan • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC